Novo Nordisk A/S Share Price

Equities

NOVO B

DK0062498333

Pharmaceuticals

Market Closed - Nasdaq Copenhagen 15:59:55 17/05/2024 BST 5-day change 1st Jan Change
903.3 DKK -1.05% Intraday chart for Novo Nordisk A/S +2.28% +29.39%

Financials

Sales 2024 * 289B 42.17B 3,320B Sales 2025 * 349B 50.87B 4,005B Capitalization 4,007B 584B 45,962B
Net income 2024 * 104B 15.2B 1,197B Net income 2025 * 127B 18.45B 1,452B EV / Sales 2024 * 13.9 x
Net Debt 2024 * 13.34B 1.94B 153B Net cash position 2025 * 12.63B 1.84B 145B EV / Sales 2025 * 11.4 x
P/E ratio 2024 *
38.9 x
P/E ratio 2025 *
31.9 x
Employees 66,015
Yield 2024 *
1.31%
Yield 2025 *
1.57%
Free-Float 70.17%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.05%
1 week+2.28%
Current month+0.08%
1 month+4.71%
3 months+6.16%
6 months+30.10%
Current year+29.39%
More quotes
1 week
883.20
Extreme 883.2
927.00
1 month
826.70
Extreme 826.7
927.00
Current year
688.80
Extreme 688.8
932.00
1 year
504.40
Extreme 504.4
932.00
3 years
237.73
Extreme 237.725
932.00
5 years
155.30
Extreme 155.3
932.00
10 years
109.10
Extreme 109.1
932.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 31/12/90
Director of Finance/CFO 53 31/12/98
Chief Tech/Sci/R&D Officer - 30/09/15
Members of the board TitleAgeSince
Director/Board Member 63 18/03/15
Chairman 61 22/03/17
Director/Board Member 68 28/02/18
More insiders
Date Price Change Volume
17/05/24 903.3 -1.05% 2,115,167
16/05/24 912.9 -0.46% 3,350,700
15/05/24 917.1 +0.78% 2,120,311
14/05/24 910 +0.01% 3,118,148

Delayed Quote Nasdaq Copenhagen, May 17, 2024 at 03:59 pm

More quotes
Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
903.3 DKK
Average target price
909.2 DKK
Spread / Average Target
+0.66%
Consensus
  1. Stock Market
  2. Equities
  3. NOVO B Stock